Alkermes News, Alkermes Quote, ALKS Quote

Alkermes (NQ:ALKS) Delayed: 44.66 +0.15 (0.34%)

Prev. Close

$44.51

Today 6M 1Y 5Y

Open

$45.25

52 Wk High

$80.71

52 Wk Low

$27.14

Day High

$45.76

Day Low

$44.63

P/E

343.54

EPS

$0.13

Volume

427,681

Friends, Peers and Foes (?): AVDL, CNTA, AMGN, AXSM, BHVN (more...)

ALERTS | RSS

Jun 18, 2026 07:05 AM Alkermes (ALKS) PT Raised to $54 at Needham
Jun 18, 2026 06:43 AM H.C. Wainwright Reiterates Neutral Rating on Alkermes (ALKS)
Jun 17, 2026 04:15 PM Alkermes narcolepsy drug meets phase 2 trial endpoints
Jun 17, 2026 04:15 PM Alkermes Presents Detailed Positive Results From Vibrance-2 Phase 2 Study of Alixorexton in Adults With Narcolepsy Type 2 at SLEEP 2026
Jun 15, 2026 07:10 AM Form 8-K Alkermes plc. For: Jun 15
Jun 15, 2026 07:02 AM Alkermes receives orphan drug status for alixorexton in U.S. and Europe
Jun 15, 2026 07:00 AM Alkermes Announces Orphan Drug Designations for Alixorexton in the U.S. and Europe
Jun 12, 2026 08:04 PM Form 4 Alkermes plc. For: Jun 12 Filed by: Wright Christopher I
Jun 12, 2026 04:19 PM Form 144 Alkermes plc. Filed by: Wright Christopher I
Jun 9, 2026 07:33 AM Alkermes (ALKS) PT Raised to $56 at RBC Capital; 'Don't Sleep On The Pipeline'

Entities mentioned with ALKS

View All Entities